English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduChildren with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Tag: Cancer
MD Anderson Research Highlights: ASCO 2022 Special Edition
This special edition features upcoming oral presentations by MD Anderson researchers at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting focused on quality improvement, health services research, new treatments for skin cancers, and symptoms and survivorship advances. More information on ASCO content from MD Anderson can be found at MDAnderson.org/ASCO.
Cancer and mental health: Mayo Clinic expert dispels myths
Everyone with cancer experiences it differently and all emotions are valid and important, regardless of the mix or intensity. Shawna Ehlers, Ph.D., a Mayo Clinic psychologist and psycho-oncology expert, helps patients cope with the burden of their cancer diagnosis. That includes dispelling myths that stress in their lives caused their cancer or that depression must be suffered through during cancer treatment.
Internationally renowned cancer researcher joins cancer center’s leadership team
UC Davis Comprehensive Cancer Center has a new chief science officer and associate director for basic science. Xiao-Jing Wang comes from the University of Colorado Anshutz Medical Campus where she focused on skin as well as head and neck cancers
A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer
Scientists at the University of Michigan fabricated a nanoparticle to deliver an inhibitor to brain tumor in mouse models, where the drug successfully turned on the immune system to eliminate the cancer. The process also triggered immune memory so that a reintroduced tumor was eliminated—a sign that this potential new approach could not only treat brain tumors but prevent or delay recurrences.
Scientists Discover Gene Plays Critical Role in Embryo Development
A new study co-led by a Cedars-Sinai investigator identified a gene that plays an important role in a biological pathway involved in embryo development. The gene’s impact at the cellular level could explain why some babies are born with physical abnormalities and why some adults develop diseases such as cancer. The findings are published in Nature Communications.
Sidekick Microbubbles Carry Anti-Cancer Drugs, Damage Tumor Vessels #ASA182
Naomi Matsuura, of the University of Toronto, and her team are adapting microbubbles to become more potent tools for cancer therapy. By shrinking the bubbles and directly loading them with anti-cancer drugs, the bubbles can lower the dose of free drug that is injected and diffuses into nontumor tissue in the body. This results in more targeted treatment and fewer side effects for the patient. Matsuura will discuss her team’s results in her presentation, “Ultrasound-stimulated, drug-loaded bubbles for cancer therapy,” as part of the 182nd Meeting of the Acoustical Society of America at the Sheraton Denver Downtown Hotel. The session will take place May 24 at 11:30 a.m. Eastern U.S.
DeepGI AI – A Thai Innovation for the Precision in Colorectal Polyp Detection
Chula Engineering and Chula Medicine co-invent an innovative device for a rapid gastrointestinal cancer detection that yields accurate results hoping to foster preventive medicine in gastrointestinal malignancy and reduce the number of cancer patients.
Rutgers Cancer Institute and RWJBarnabas Health Experts Available for Comment on Skin Cancer and Sun Safety through Summer Months
New Brunswick, N.J., May 23, 2022– According to the American Cancer Society, skin cancer is the most common type of cancer. While we all want to enjoy the outdoors this summer, increased fun in the sun means an increased risk…
Breakthrough COVID infections more likely in cancer and Alzheimer’s patients, studies find
Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer’s patients, according to two new studies from researchers at the Case Western Reserve University School of Medicine.
Scientists Find Sea Corals are Source of Sought After “Anti-Cancer” Compound
The bottom of the ocean is full of mysteries but scientists have recently uncovered one of its best-kept secrets. For 25 years, drug hunters have been searching for the source of a natural chemical that had shown promise in initial studies for treating cancer. Now, researchers at University of Utah Health report that easy-to-find soft corals make the elusive compound.
Medicinal cannabis shown to reduce pain and need for opiate painkillers among cancer patients
A comprehensive assessment of the benefits of medical cannabis for cancer-related pain found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.
Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.
Grant from Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer
Research to Prevent Blindness and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.
Retired Science Teacher Relies on Former Student When Faced With Bladder Cancer
Intravesical chemotherapy, is specifically for patients with recurrent non-muscle bladder cancers that aren’t responding to BCG. Up to 50 percent of patients respond to this therapy, helping them avoid major surgery.
Exploring Cancer and Health Data on Asian American and Pacific Islanders
Cancer health disparities are often identified from population-based surveillance data routinely captured by statewide cancer registries. Antoinette Stroup, PhD, of Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute – Designated Comprehensive Cancer Center together with RWJBarnabas Health and Rutgers School of Public Health is the director of the New Jersey State Cancer Registry (NJSCR), explores cancer and health data on the Asian American and Pacific Islander population.
Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.
Penn Medicine Study Reveals Imaging Approach with Potential to Detect Lung Cancer Earlier, at the Cellular Level
Researchers at the Abramson Cancer Center at the University of Pennsylvania have found a way to identify lung cancer at the cellular level in real time during a biopsy, offering promise in the ability to detect the disease earlier and with more confidence. The research is published this week in Nature Communications.
New Study Finds Medicaid Expansion Increases Survival in Newly Diagnosed Cancer Patients
A new large study led by researchers at the American Cancer Society (ACS) shows Medicaid expansion under the Affordable Care Act (ACA) was associated with an increase in two-year overall survival rates among patients newly diagnosed with cancer, especially among non-Hispanic Black people and people living in rural areas.
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced $29.5M in new funding led by Mr. Harry Stine of Stine Seed Farms, Inc.
ASMBS ANNUAL MEETING 2022 — DALLAS – Scientific Theme – A Pathway to Cancer Prevention
The 38th annual meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS)
Groundbreaking for Major Expansion of University of Maryland Greenebaum Comprehensive Cancer Center
The University of Maryland Medical Center celebrates the groundbreaking of a nine-story patient care tower – the Roslyn and Leonard Stoler Center for Advanced Medicine – that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. The $219 million building will enable the cancer center to provide the most technologically advanced, integrated care to cancer patients throughout Maryland and the region well into the future
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma
A study published by researchers from Mayo Clinic Cancer Center at Mayo Clinic in Florida and Case Western, Cleveland Medical Center, investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma treated with chimeric antigen receptor-T cell therapy (CAR-T cell therapy).
Delays in surgery for advanced esophageal cancer result in significantly worse survival than early surgery
Delays in surgery for esophageal cancer did not appear to have much impact on patients’ relative survival for early-stage cancer compared with patients who had surgery early, but they did reduce the relative survival rate by almost half for patients with more advanced disease.
Fast-tracked: First in-human trial for aggressive brain tumours
A novel technology designed to precisely image aggressive brain cancers and guide treatment is being developed by the University of South Australia and Australian cancer diagnostic company, Ferronova, potentially helping thousands of people who are diagnosed with the deadly condition each year.
New Study Reports Need to Monitor Public Interest in Shopping and Sales of Popular Puff Bar E-cigarette Brand
New research led by scientists at the American Cancer Society shows the need for continued surveillance of the changes in shopping interest and sales for Puff Bar, the most preferred brand of electronic cigarettes or e-cigarettes among youth in the United States. Public interest in shopping and sales of Puff Bar skyrocketed in 2020.
Smoking-cessation program that targets cancer patients effective
Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have found a way to help more patients who want to stop smoking. The successful strategy involves using electronic medical records to help identify smokers when they visit their oncologists and offering help with quitting during such visits.
Discovery of cell protein that keeps Kaposi’s sarcoma herpesvirus dormant
A study led by UC Davis Cancer Center identified a binding protein in cancer cell’s nucleus, known as CHD4, as a critical agent keeping Kaposi’s sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body’s immune system. CHD4 is linked to cancer cell growth in many types of cancers.
LUDWIG MSK STUDY MODELING TUMOR EVOLUTION REVEALS A VULNERABILITY FOR CANCER PREVENTION AND THERAPY
Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of genes essential to cancer growth appear to be more frequently mutated than others in established tumors.
Honoring Rutgers Cancer Institute of New Jersey Nurses
Two nurses are named recipients of Rutgers Cancer Institute’s ‘Oncology Nursing Excellence Awards’ during Nurses Week each year. This year’s award recipients were named during the annual Elizabeth Gibby Osborne Lecture today.
Descoberta da Mayo Clinic sobre câncer de medula óssea aponta para possíveis alvos de medicamentos
Uma nova pesquisa do Centro de Medicina Individualizada da Mayo Clinic descobre que pacientes com leucemia mielomonocítica crônica com mutação ASXL1 (um tipo incomum de câncer de medula óssea) têm alterações epigenéticas específicas que podem ativar genes nocivos e fazer com que o câncer cresça mais rapidamente.
Exposure to wildfires increases risk of cancer
A new study from McGill University finds higher incidence of lung cancer and brain tumors in people exposed to wildfires.
Henry Ford Health First in Michigan to Offer Robotic High-Intensity Focused Ultrasound for Prostate Cancer
Henry Ford Health is the first in Michigan to offer Robotic High Intensity Focused Ultrasound (HIFU) for the treatment of localized prostate cancer. This non-surgical treatment option spares surrounding healthy tissue, while allowing for a quicker treatment time and recovery for the patient.
Rutgers-Led Effort Is Close to Getting Uterine Cancer Covered by WTC Health Program
A proposed rule change would improve care and compensation for responders and survivors who developed uterine cancer after Ground Zero exposure
Drugs showing promise in cancer trials reduce scarring for scleroderma, study shows
Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, a new study shows. Results reveal that drugs that inhibit BRD4, known to play a role in cancer, also affect fibrosis in scleroderma. Researchers tested BRD4 inhibitors on the skin fibroblasts of scleroderma patients and in mouse models of skin fibrosis, finding that the treatment stopped scarring in both human-derived cells and in animals.
Targeting Cervical Cancer Stem Cells to Improve Outcomes
The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.
Câncer colorretal aumenta em adultos jovens: especialista da Mayo Clinic explica os fatores de risco
As taxas de câncer colorretal em pessoas com menos de 50 anos estão aumentando ao redor do mundo. Jeremy Jones, M.D., oncologista da Mayo Clinic em Jacksonville, Flórida, descreve os fatores de risco que as pessoas podem evitar e os sinais de alerta que devem ser levados a sério em qualquer idade.
Using AI to predict bone fractures in cancer patients
As medicine continues to embrace machine learning, a new study suggests how scientists may use artificial intelligence to predict how cancer may affect the probability of fractures along the spinal column.
Patients with past cancer history not associated with higher risk of COVID-19-related death or hospitalization
Patients diagnosed with cancer more than one year ago and those not receiving active treatment were no more vulnerable to worse COVID-19 outcomes than patients without cancer, according to a new study led by UTHealth Houston.
New Study Shows Adolescent and Young Adult Cancer Survivors Face Increased Cancer Incidence and Mortality Risk
New findings led by researchers at the American Cancer Society (ACS) show that five-year survivors of adolescent and young adult (AYA) cancer in the United States have a higher risk of developing and nearly double the risk of dying from a new primary cancer as the general population.
How a bot beamed from California to Japan may prevent cancer patients from losing their breasts unnecessarily
Too many women are getting unnecessary mastectomies and other invasive procedures because of a knowledge gap about differences in cancer genes. A new study offers a path to closing the gap.
Public Beware: Study Finds Potential for Massive Cancer Nutrition Misinformation on Pinterest
A multi-center team including researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine claims that the social media site Pinterest is rife with cancer misinformation. Their study found that about a third of posts…
Pesquisadores da Mayo Clinic carregam células CAR-T com vírus oncolítico para tratar tumores sólidos
Pesquisadores do Centro de Medicina Individualizada da Mayo Clinic criaram uma técnica de imunoterapia que combina terapia de células T com receptor de antígeno quimérico, ou terapia celular CAR-T, com um vírus que mata o câncer para direcionar melhor o alvo e tratar com mais eficiência tumores de câncer sólidos.
Investigadores de Mayo Clinic llenan con virus oncolítico a células T con receptor de antígeno quimérico para tratar cáncer de tumor sólido
Los investigadores del Centro para Medicina Personalizada en Mayo Clinic inventaron una técnica de inmunoterapia que combina la terapia de células T con receptor de antígeno quimérico (CAR-T, por sus siglas en inglés) con un virus que elimina el cáncer a fin de apuntar de forma más eficiente el tratamiento contra el cáncer de tumor sólido.
Oncology specialists’ perspective on caring for patients with cancer during the early days of war in Kyiv, Ukraine
Recently, members of The Institute for Cancer Care at Mercy Medical Center oncology research team, working in conjunction with two oncologists in war-torn Ukraine, developed a report now appearing in THE LANCET/Oncology, describing the challenges faced in cancer care delivery under…
Harrington Discovery Institute Announces 2022 Grant Funding to 11 Physician-Scientists
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2022 class of Harrington Scholar-Innovators. The scholar awards will support a diverse set of drug discovery projects including new treatments for pulmonary diseases, COVID-19, multiple cancers, corneal disease, hepatitis, and acquired spinal cord injuries.
Johns Hopkins Students Create Lymphedema Early Detection Sensor
A sensor created by Johns Hopkins University graduate students to detect very early-stage lymphedema could spare thousands of patients a year, many women with breast cancer, from the painful, debilitating condition.
Scientists awaken viral response to target bowel cancer
New research has identified the role of the immune response within bowel cancer tissue, which could lead to new lifesaving treatments for bowel cancer patients.
Studies Find Increase in Use of Proton Beam Therapy for Cancer Care and Increase in Racial Disparities
Two new large studies led by researchers at the American Cancer Society (ACS) show an increase in the use of proton beam therapy (PBT) for patients with cancer in the United States during the past decade.
The Medical Minute: Getting ahead of head and neck cancer
The warning signs of head and neck cancer can be easy to miss. But according to a Penn State Health physician, prevention is possible.